FDA 483 - Central Solutions Inc - November 21, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Central Solutions Inc, an OTC drug, medical device, and cosmetic manufacturer in Kansas City, revealed significant deficiencies in quality control and manufacturing practices. The firm failed to thoroughly investigate discrepancies, justify deviations from specifications, and maintain adequate written procedures for production, process controls, and stability testing. Additionally, issues were noted with equipment cleaning, raw material release, and employee training.
ID · 07884c6b-ec69-4b46-9bac-9b64faac36a1